
Dr. Campbell Le Heron
Dr. Campbell Le Heron is a Christchurch-based dementia specialist and principal investigator in New Zealand for the DIAN-TU 001 clinical trial, which explores new generation drugs aimed at slowing the progression of Alzheimer’s disease, particularly in patients with the rare PSEN1 gene mutation.
Power525
Reach12,056
Country presence
Recent news mentions
Dr. Campbell Le Heron is a dementia specialist who acknowledges the challenges of new Alzheimer’s treatments.
With new blood tests for Alzheimer’s and next-gen drugs that may slow its progression, is there hope at last?The New Zealand Herald – country’s largest newspaper, est. 1863·
New Zealand· 2026-06-02






